-RARα kinetics and impact of FLT3-ITD mutations in newly diagnosed acute promyelocytic leukaemia treated with ATRA and ATO or ATRA and chemotherapy. Leukemia 2016; 30(10): 1987
Jones, G., Parry-Jones, N., Wilkins, B., et al.: Revised guidelines for the diagnosis and management of hairy cell leukaemia and hairy cell leukeamia variant. Br. J. Haem., 2012, 156 , 186
701 708 Johnstone, W. R., Cretney, E., Smyth, J. M.: P-glycoprotein protects leukemia cells against caspase-dependent, but not caspase-independent cell death
Colombat, M., Fort, M. P., Chollet, C. és mtsai: Molecular remission in chronic myeloid leukemia patients with sustained complete cytogenetic remission after imatinib mesylate treatment
myeloid leukemia. [A krónikus myeloid leukaemia kezelésének finanszírozási eljárásrendje.] Magyar Közlöny, 2014, (11), 1715–1722. [Hungarian] 4 O’Brien, S. G., Guilhot
Irodalom 1 Famenini S, Martires KJ, Zhou H, et al. Melanoma in patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma. J Am Acad Dermatol. 2015; 72(1): 78
normal acute myeloid leukemia. Haematologica, 2011, 96, 1613–1618. 2 Patel, J. P., Gönen, M., Figueroa, M. E., et al.: Prognostic relevance of integrated
Colombat, M., Fort, M. P., Chollet, C. et al.: Molecular remission in chronic myeloid leukemia patients with sustained complete cytogenetic remission after imatinib mesylate treatment
Chena, C., Arrossagarasy, G, Scolnik, M. és mtsai: Interphase cytogenetic analysis in Argentinean B-cell chronic lymphocytic leukemia patients: association of trisomy 12 and del(13q14). Cancer
Demeter J.: Hajas sejtes leukaemia (HSL) és a rokon betegségek (HSL-variáns, splenikus lymphoma villosus lymphocytákkal /SLVL/). In: Hematológiai betegségek kezelése (szerk. Lehoczky D.), Documed
